Cargando…

PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma

Protein arginine methyltransferase 5 (PRMT5), a histone methyltransferase responsible for the symmetric dimethylation of histone H4 on Arg 3 (H4R3me2s), is an enzyme that participates in tumor cell progression in a variety of hematological malignancies. However, the biological functions of PRMT5 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Tian, Liu, Ming, Zhao, Quan, Ouyang, Jian, Xu, Peipei, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445991/ https://www.ncbi.nlm.nih.gov/pubmed/34531375 http://dx.doi.org/10.1038/s41419-021-04125-5

Ejemplares similares

Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Xia, Tian, et al.
Publicado: (2021)

PRMT5 inhibitors on the (myeloma) road
por: Gulla, Annamaria, et al.
Publicado: (2018)

Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis
por: Liu, Wantao, et al.
Publicado: (2023)

Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma
por: Chen, Yajun, et al.
Publicado: (2022)

Unsupervised Integration of Multiple Protein Disorder Predictors: The Method and Evaluation on CASP7, CASP8 and CASP9 Data
por: Zhang, Ping, et al.
Publicado: (2011)

Protein Arginine Methyltransferase 5 (PRMT5) has prognostic relevance and is a druggable target in Multiple Myeloma
por: Gullà, Annamaria, et al.
Publicado: (2017)

Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making
por: Zhu, Jun, et al.
Publicado: (2023)

Influence of the naturally occurring human CASP1 variant L265S on subcellular distribution and pyroptosis
por: Rabe, S, et al.
Publicado: (2015)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
por: Vlummens, Philip, et al.
Publicado: (2022)

A novel prognostic model based on pyroptosis-related genes for multiple myeloma
por: Zhang, Cuiling, et al.
Publicado: (2023)

Benzene metabolites trigger pyroptosis and contribute to haematotoxicity via TET2 directly regulating the Aim2/Casp1 pathway
por: Guo, Xiaoli, et al.
Publicado: (2019)

The methyltransferase PRMT1 regulates γ-globin translation
por: Wang, Ying, et al.
Publicado: (2021)

PRMT5-mediated regulation of developmental myelination
por: Scaglione, Antonella, et al.
Publicado: (2018)

PRMT5 in gene regulation and hematologic malignancies
por: Zhu, Fen, et al.
Publicado: (2019)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
por: Nakayama, Kazuhide, et al.
Publicado: (2018)

PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression
por: Liu, Ming, et al.
Publicado: (2020)

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
por: Hartley, Antja-Voy, et al.
Publicado: (2020)

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis
por: Xu, Peipei, et al.
Publicado: (2019)

Polycomb Target Genes Are Silenced in Multiple Myeloma
por: Kalushkova, Antonia, et al.
Publicado: (2010)

CASP+ Practice Tests
por: Tanner, Nadean
Publicado: (2020)

PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach
por: Barbarino, Marcella, et al.
Publicado: (2020)

Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma
por: Xu, Peipei, et al.
Publicado: (2019)

The Methyltransferases PRMT4/CARM1 and PRMT5 Control Differentially Myogenesis in Zebrafish
por: Batut, Julie, et al.
Publicado: (2011)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023)

PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades
por: Yan, Yongrong, et al.
Publicado: (2021)

Association Between a Polymorphism in CASP3 and CASP9 Genes and Ischemic Stroke
por: Lee, Bae Youl, et al.
Publicado: (2017)

PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019)

PRMT5 function and targeting in cancer
por: Kim, Hyungsoo, et al.
Publicado: (2020)

The Role of PRMT5 in Immuno-Oncology
por: Abe, Yoshinori, et al.
Publicado: (2023)

G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells
por: Huang, Tianhao, et al.
Publicado: (2017)

PRMT5 promotes colorectal cancer growth by interaction with MCM7
por: Li, Xiangwei, et al.
Publicado: (2021)

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact
por: Li, Zhenhai, et al.
Publicado: (2019)

Integrative Analysis of a Pyroptosis-Related Signature of Clinical and Biological Value in Multiple Myeloma
por: Wang, Huizhong, et al.
Publicado: (2022)

Epigenetic silencing of LPP/miR-28 in multiple myeloma
por: Li, Zhenhai, et al.
Publicado: (2018)

The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR(L) in human lung cancer cells
por: Li, Mingyue, et al.
Publicado: (2019)

The Structure and Functions of PRMT5 in Human Diseases
por: Motolani, Aishat, et al.
Publicado: (2021)

PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
por: Lee, Michael K. C., et al.
Publicado: (2021)

Antitumor Effects of PRMT5 Inhibition in Sarcomas
por: Verbeke, Stéphanie, et al.
Publicado: (2023)

Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis
por: Wang, Chenfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3em46vtr17p1pb1komm1dil1dn